For its second quarter, the apparel and hosiery giant posted net income of $154.58 million, or $1.51 a share, up from $121.59 million, or $1.19 a share in the previous-year quarter. Included in the results were charges of 20 cents a share related to the acquisition of Maidenform Brands, Inc., and other actions.
Adjusted earnings were $1.71 a share, ahead of analysts’ average estimate for $1.50 a share.
Net sales grew 11.9% to $1.34 billion from $1.20 billion in the same period last year, reflecting the acquisition of Maidenform and on Activewear segment growth. Analysts’ consensus estimate was for $1.35 billion in sales.
All four apparel categories showing solid gains despite what HanesBrands called “a continuing uncertain economic environment.” Innerwear sales, which include hosiery, rose 14.7% to $788.3 million, while Activewear was up 8% to $317.8 million, direct to consumer up 12.7% to $104.3 million and international up 5.2% to $131.5 million.
Gross margin for the quarter was 37.6%, up from 36.3% in the year-ago quarter. Operating margin edged up to 15.4% from 15.1% last year.
Cost of sales increased 9.7% to $837.7 million, and selling, general and administrative expenses rose 17% to $297.2 million.
Chairman/CEO Richard Noll touted the company’s innovate-to-elevate apparel strategy, along with its global supply chain, for the quarterly performance. The strategy emphasizes value-added products that can be made at a lower cost and sold at a higher price.
“We remain confident in our business model and our performance momentum,” Noll said.
Looking ahead, HanesBrands raised its outlook based upon its net income increase and its acquisitions. Now the company expected full year earnings to increase by 40 cents to a range of $5.20 to $5.40. Adjusted operating profit, which excludes one-time integration and other charges, was lifted by $45 million to a range of $710 million to $730 million. Revenue projections are for $5.07 billion.
Meanwhile, analysts forecast earnings of $4.99 a share for the year on revenues of $5.18 billion.
For commercial purposes, extract supplements can be obtained from the fruit of the pericarp. Garcinia cambogia reviews is performed by a physician Chen and Oz to prove that it is an herb for weight loss, a lot of research has been done. Studies, Garcinia cambogia extract supplementation decreases the weight of the body fat accumulation, was shown to have a positive effect on prevention. We are important substances such as cholesterol (LDL), reduces the serum leptin and triglycerides. In addition, it will increase the level of serotonin and cholesterol (HDL). The study also, Garcinia cambogia extract supplements, has proven that there are no significant adverse effects on many of the eight weeks, such as its use.